Prelude Capital Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.4K | Sell |
14,481
-6,837
| -32% | -$34.7K | 0.01% | 932 |
|
|
2025
Q1 | $64.4K | Buy |
21,318
+11,240
| +112% | +$33.9K | ﹤0.01% | 991 |
|
|
2024
Q4 | $36.5K | Buy |
+10,078
| New | +$36.5K | ﹤0.01% | 1030 |
|
|
2016
Q1 | – | Sell |
-331
| Closed | -$46K | – | 1486 |
|
|
2015
Q4 | $46K | Buy |
331
+310
| +1,476% | +$43.1K | 0.01% | 999 |
|
|
2015
Q3 | $3K | Buy |
+21
| New | +$3K | ﹤0.01% | 1329 |
|